Lakefront Biotherapeutics (LKFT) EBITDA Margin (QoQ) (2016 - 2026)
Lakefront Biotherapeutics (LKFT) EBITDA Margin (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106,698.00 |
| Dec 31, 2025 | 73,135.00 |
| Sep 30, 2025 | -88,803.00 |
| Jun 30, 2025 | 45,241.00 |
| Mar 31, 2025 | -83,168.00 |
| Dec 31, 2024 | 72,266.00 |
| Sep 30, 2024 | 9,556.00 |
| Jun 30, 2024 | -14,515.00 |
| Mar 31, 2024 | -24,657.00 |
| Dec 31, 2023 | 21,673.00 |
| Sep 30, 2023 | -74.00 |
| Jun 30, 2023 | 175.00 |
| Mar 31, 2023 | -2,645.00 |
| Dec 31, 2022 | 15,189.00 |
| Sep 30, 2022 | 21,410.00 |
| Jun 30, 2022 | -21,705.00 |
| Mar 31, 2022 | -14,855.00 |
| Dec 31, 2021 | 288,214.00 |
| Sep 30, 2021 | -284,688.00 |
| Jun 30, 2021 | -3,340.00 |